Tervala Tomi, Suominen Erkki, Saaristo Anne
Department of Plastic Surgery, Turku University Central Hospital, Turku, Finland.
Ann N Y Acad Sci. 2008;1131:215-24. doi: 10.1196/annals.1413.019.
The presence of lymphatic vessels has been known for centuries, but the key players regulating the lymphatic vessel growth and function have only been discovered during the recent decade. The lymphatic vasculature is essential for maintenance of normal fluid balance and for the immune response. Hypoplasia or dysfunction of the lymphatic vessels can lead to lymphedema. Currently, lymphedema is treated primarily by physiotherapy, compression garments, and occasionally by surgery, but the means to reconstitute the collecting lymphatic vessels and cure the condition are limited. Specific growth factor therapy has been used in experimental models to regenerate lymphatic capillaries and collecting vessels after surgical damage. Recent results provide a new concept of combining growth factor therapy with lymph node transplantation as a rationale for treating secondary lymphedema. Lymphatic vessels are also involved in lymph node and systemic metastasis of cancer cells; our understanding of mechanisms of lymphatic metastasis has increased remarkably.
淋巴管的存在已为人所知数百年,但调控淋巴管生长和功能的关键因素直到最近十年才被发现。淋巴脉管系统对于维持正常的液体平衡和免疫反应至关重要。淋巴管发育不全或功能障碍可导致淋巴水肿。目前,淋巴水肿主要通过物理治疗、压力衣进行治疗,偶尔也会进行手术,但重建集合淋巴管并治愈该病的方法有限。在实验模型中,特定生长因子疗法已被用于在手术损伤后使淋巴毛细血管和集合血管再生。最近的研究结果提出了将生长因子疗法与淋巴结移植相结合的新概念,作为治疗继发性淋巴水肿的理论依据。淋巴管也参与癌细胞的淋巴结转移和全身转移;我们对淋巴转移机制的理解有了显著提高。